“Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study)”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s262. https://doi.org/10.25251/skin.7.supp.262.